Teladoc Health (TDOC) Shares Outstanding (Weighted Average) (2013 - 2026)

Teladoc Health has disclosed Shares Outstanding (Weighted Average) across 14 years of filings, most recently posting $179.1 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $179.1 million, up 2.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $179.1 million (up 2.85% YoY), and the FY2025 annual result was $176.2 million, up 3.32% from the prior year.
• Shares Outstanding (Weighted Average) came in at $179.1 million for Q1 2026 at Teladoc Health, up from $176.2 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $179.1 million in Q1 2026 to a low of $161.0 million in Q2 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $168.4 million (2024), against an average of $168.5 million.
• Across the five-year window, Shares Outstanding (Weighted Average) gained 1.58% in 2023 and grew 3.83% in 2025, its largest moves.
• Teladoc Health's Shares Outstanding (Weighted Average) stood at $161.5 million in 2022, then rose by 1.93% to $164.6 million in 2023, then climbed by 3.64% to $170.6 million in 2024, then climbed by 3.32% to $176.2 million in 2025, then advanced by 1.65% to $179.1 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $179.1 million (Q1 2026), $176.2 million (Q4 2025), and $175.7 million (Q3 2025), per Business Quant data.